共 50 条
- [1] HER2 positive breast cancer patients having HER2 loss after neoadjuvant chemotherapy should still be treated with adjuvant anti-HER2 treatment[J]. Breast Cancer Research and Treatment, 2019, 175 : 261 - 261Kadri Altundag
- [2] Anti-HER2 neoadjuvant and adjuvant therapies in HER2 positive breast cancer[J]. CANCER TREATMENT REVIEWS, 2010, 36 : S62 - S66Guarneri, V.Barbieri, E.Dieci, M. V.Piacentini, F.Conte, P.
- [4] Is HER2 loss after neoadjuvant chemotherapy determinant for the choice of adjuvant treatment in HER2 positive breast cancer patients? Reply[J]. JOURNAL OF SURGICAL ONCOLOGY, 2018, 117 (02) : 329 - 329Yoshida, AtsushiHayashi, Naoki
- [5] Should patients with HER2 loss after neoadjuvant treatment still be treated with adjuvant trastuzumab treatment?[J]. JOURNAL OF BUON, 2017, 22 (04): : 1085 - 1085Altundag, Kadri
- [6] Anti-HER2 Drugs for the Treatment of Advanced HER2 Positive Breast Cancer[J]. CURRENT TREATMENT OPTIONS IN ONCOLOGY, 2023, 24 (11) : 1633 - 1650Stanowicka-Grada, MalwinaSenkus, Elzbieta
- [7] Change in HER2 Status in HER2 Positive Operable Breast Cancer Patients Treated with Neoadjuvant Chemotherapy with or without Anti-HER2 Therapy: Analysis of Two Consecutive Cohorts[J]. CANCER RESEARCH, 2011, 71Barbieri, E.Piacentini, F.Dieci, M. V.Ficarra, G.Bettelli, S.Conte, P.Guarneri, V.
- [8] Anti-HER2 Drugs for the Treatment of Advanced HER2 Positive Breast Cancer[J]. Current Treatment Options in Oncology, 2023, 24 : 1633 - 1650Malwina Stanowicka-GradaElżbieta Senkus
- [9] The perspective of anti-HER2 therapy for HER2 positive breast cancer[J]. ANNALS OF ONCOLOGY, 2015, 26 : 11 - 11Iwata, Hiroji
- [10] Prognostic significance and evolution of HER2 zero, HER2 low and HER2 positive in breast cancer after neoadjuvant treatment[J]. ANNALS OF ONCOLOGY, 2023, 34 : S301 - S302Wei, T.Wang, D.Peng, Y.